-
FAST TREATMENT EFFICACY TESTING VIA REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
POST HOC ANALYSIS OF PATIENT AND TREATMENT CHARACTERISTICS BY VONOPRAZAN TREATMENT DURATION: RESULTS FROM PATIENTS WITH REFLUX OESOPHAGITIS IN THE VIEW STUDY
Mar 18, 2026, 21:38 PM -
EXAMINATION OF PROTECTIVE AND RISK FACTORS DETERMINING THE PROFESSIONAL QUALITY OF LIFE OF PUBLIC HEALTH NURSES
Mar 18, 2026, 21:38 PM -
INCIDENCE AND RISK FACTORS FOR SEXUALLY TRANSMITTED DISEASES FOLLOWING SOLID ORGAN TRANSPLANT, HEMATOPOIETIC STEM CELL TRANSPLANTATION, AND CAR T-CELL THERAPY
Mar 18, 2026, 21:38 PM -
A COMPARATIVE ANALYSIS OF LARGE LANGUAGE MODELS IN TITLE AND ABSTRACT SCREENING GUIDED BY HUMAN OVERSIGHT
Mar 18, 2026, 21:38 PM -
BAYESIAN MULTI-PARAMETER EVIDENCE SYNTHESIS FOR INFORMED INDIRECT TREATMENT COMPARISONS OF EXTRAPOLATED SURVIVAL OUTCOMES
Mar 18, 2026, 21:38 PM -
DELAYING DECLINE, REDUCING DEMAND: NEAR-TERM UTILIZATION AND COSTS ASSOCIATED WITH PROGRESSION OF ALZHEIMER’S DISEASE AMONG US MEDICARE BENEFICIARIES
Mar 18, 2026, 21:38 PM -
VARIATION IN COMMERCIAL HEALTH PLAN COVERAGE OF ATOPIC DERMATITIS THERAPIES
Mar 18, 2026, 21:38 PM -
PERSONALITY PROFILES AND BURNOUT DIMENSIONS AMONG EMERGENCY CARE PROFESSIONALS IN HUNGARY: A CROSS-SECTIONAL STUDY
Mar 18, 2026, 21:38 PM -
HEALTHCARE UTILIZATION PATTERNS AMONG MEDICARE BENEFICIARIES WITH FINANCIAL CONSTRAINTS
Mar 18, 2026, 21:38 PM -
COST EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB? VERSUS CYCLOSPORINE A IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY
Mar 18, 2026, 21:38 PM -
WHAT HEOR CAN LEARN FROM MATURE AI INDUSTRIES AND WHERE THE ANALOGIES BREAK DOWN
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF CANCER-RELATED PRODUCTIVITY LOSSES IN HIGH-INCOME AND MIDDLE-INCOME ASIA-PACIFIC MARKETS: TRENDS FROM 2010 TO 2022
Mar 18, 2026, 21:38 PM -
THE IMPACT OF ESKETAMINE ON ALZHEIMER’S DISEASE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT AND MAJOR DEPRESSIVE DISORDER: A TARGET TRIAL EMULATION
Mar 18, 2026, 21:38 PM -
PREVALENCE OF CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME AMONG OLDER WOMEN WITH BREAST CANCER IN THE 2011-2021 SEER-MEDICARE DATA
Mar 18, 2026, 21:38 PM -
GENE THERAPY DEVELOPMENT PROGRAMS ARE BOTH GROWING AND EVOLVING IN THE FACE OF COMMERCIAL HEADWINDS
Mar 18, 2026, 21:38 PM -
INTEGRATION OF GENERATIVE ARTIFICIAL INTELLIGENCE INTO THE DEVELOPMENT OF STATISTICAL ANALYSIS PLANS FOR PATIENT-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
MEDICATION-TAKING BEHAVIOUR IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD): A QUALITATIVE ANALYSIS OF SOCIAL MEDIA DATA
Mar 18, 2026, 21:38 PM -
EVALUATING THE PERFORMANCE OF A GENERATIVE ARTIFICIAL INTELLIGENCE CHATBOT FOR ASSESSING SYSTEMATIC LITERATURE REVIEWS USING THE PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META-ANALYSES 2020 CHECKLIST
Mar 18, 2026, 21:38 PM -
INCREASING UTILITY OF INTEGRATED REAL-WORLD EVIDENCE THROUGHOUT THE PRODUCT LIFECYCLE TO SUPPORT HEALTHCARE REIMBURSEMENT
Mar 18, 2026, 21:38 PM
